Reversible cardiogenic shock following 5-fluorouracil infusion

Charles Ferté; Carlos Gomez Roca; Yohann Loriot; Rastislav Bahleda; Cristian Moldovan; Ariel Cohen; Hassan Izzedine; Jean Charles Soria; Stephane Ederhy

doi:10.1007/s10637-009-9271-3

Reversible cardiogenic shock following 5-fluorouracil infusion

Charles Ferté, Carlos Gomez Roca, Yohann Loriot, Rastislav Bahleda, Cristian Moldovan, Ariel Cohen, Hassan Izzedine, Jean Charles Soria, Stephane Ederhy

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

2 Citations (Scopus)

Résumé

5-fluorouracil remains a major component of chemotherapy regimens for various tumors. We report the case of reversible cardiogenic shock following 5-FU administration and discuss the different pitfalls of such toxicity. Oncologist should be aware of that rare but potentially lethal adverse event.

langue originale	Anglais
Pages (de - à)	531-533
Nombre de pages	3
journal	Investigational New Drugs
Volume	28
Numéro de publication	4
Les DOIs	https://doi.org/10.1007/s10637-009-9271-3
état	Publié - 1 août 2010

Accès au document

10.1007/s10637-009-9271-3

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{165a08fe4137416690c7e2839a413fbd,

title = "Reversible cardiogenic shock following 5-fluorouracil infusion",

abstract = "5-fluorouracil remains a major component of chemotherapy regimens for various tumors. We report the case of reversible cardiogenic shock following 5-FU administration and discuss the different pitfalls of such toxicity. Oncologist should be aware of that rare but potentially lethal adverse event.",

keywords = "5-Fluorouracil, Cardiogenic shock, Toxicity",

author = "Charles Fert{\'e} and Roca, {Carlos Gomez} and Yohann Loriot and Rastislav Bahleda and Cristian Moldovan and Ariel Cohen and Hassan Izzedine and Soria, {Jean Charles} and Stephane Ederhy",

year = "2010",

month = aug,

day = "1",

doi = "10.1007/s10637-009-9271-3",

language = "English",

volume = "28",

pages = "531--533",

journal = "Investigational New Drugs",

issn = "0167-6997",

number = "4",

}

TY - JOUR

T1 - Reversible cardiogenic shock following 5-fluorouracil infusion

AU - Ferté, Charles

AU - Roca, Carlos Gomez

AU - Loriot, Yohann

AU - Bahleda, Rastislav

AU - Moldovan, Cristian

AU - Cohen, Ariel

AU - Izzedine, Hassan

AU - Soria, Jean Charles

AU - Ederhy, Stephane

PY - 2010/8/1

Y1 - 2010/8/1

N2 - 5-fluorouracil remains a major component of chemotherapy regimens for various tumors. We report the case of reversible cardiogenic shock following 5-FU administration and discuss the different pitfalls of such toxicity. Oncologist should be aware of that rare but potentially lethal adverse event.

AB - 5-fluorouracil remains a major component of chemotherapy regimens for various tumors. We report the case of reversible cardiogenic shock following 5-FU administration and discuss the different pitfalls of such toxicity. Oncologist should be aware of that rare but potentially lethal adverse event.

KW - 5-Fluorouracil

KW - Cardiogenic shock

KW - Toxicity

UR - http://www.scopus.com/inward/record.url?scp=77956635275&partnerID=8YFLogxK

U2 - 10.1007/s10637-009-9271-3

DO - 10.1007/s10637-009-9271-3

M3 - Article

C2 - 19499187

AN - SCOPUS:77956635275

SN - 0167-6997

VL - 28

SP - 531

EP - 533

JO - Investigational New Drugs

JF - Investigational New Drugs

IS - 4

ER -